
{
    "credit": [
        {
            "email": "agapito@unicz.it",
            "name": "Giuseppe Agapito",
            "typeEntity": "Person",
            "typeRoles": [
                "Primary contact"
            ]
        },
        {
            "name": "Cirino Botta",
            "typeEntity": "Person",
            "typeRoles": [
                "Contributor"
            ]
        }
    ],
    "documentation": [
        {
            "url": "https://sites.google.com/site/overallsurvivalanalyzer/home/userguide"
        }
    ],
    "function": [
        {
            "operation": [
                {
                    "term": "Incident curve plotting",
                    "uri": "http://edamontology.org/operation_3503"
                }
            ]
        }
    ],
    "labels": {
        "language": [
            "Java"
        ],
        "license": "Other",
        "operatingSystem": [
            "Linux",
            "Windows",
            "Mac"
        ],
        "toolType": [
            "Desktop application"
        ],
        "topic": [
            {
                "term": "Oncology",
                "uri": "http://edamontology.org/topic_2640"
            },
            {
                "term": "Drug metabolism",
                "uri": "http://edamontology.org/topic_3375"
            },
            {
                "term": "Microarray experiment",
                "uri": "http://edamontology.org/topic_3518"
            },
            {
                "term": "Pharmacogenomics",
                "uri": "http://edamontology.org/topic_0208"
            }
        ]
    },
    "publication": [
        {
            "doi": "10.3390/microarrays5040024",
            "pmcid": "PMC5197943",
            "pmid": "27669316",
            "type": "Primary"
        }
    ],
    "summary": {
        "biotoolsCURIE": "biotools:osanalyzer",
        "biotoolsID": "osanalyzer",
        "description": "OSAnalyzer is a software tool able to compute the overall survival (OS) and progression-free survival (PFS) of cancer patients and evaluate their association with ADME gene variants.",
        "homepage": "https://sites.google.com/site/overallsurvivalanalyzer/",
        "name": "OSAnalyzer"
    }
}